Microbio

4128.TWO

0.49 USD

0.01

+2.08%

Overview

Last close

0.49 usd

Market cap

286.39M usd

52 week high

0.97 usd

52 week low

0.42 usd

Target price

N/A usd

Valuation

P/E

17.6705

Forward P/E

1111.1111

Price/Sales

4.6535

Price/Book Value

0.9194

Enterprise Value

206.84M usd

EV/Revenue

3.3613

EV/EBITDA

11.9187

Key financials

Revenue TTM

61.53M usd

Gross Profit TTM

24.37M usd

EBITDA TTM

-11.60M usd

Earnings per Share

0.03 usd

Dividend

N/A usd

Total assets

403.54M usd

Net debt

N/A usd

About

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and health foods in Taiwan. It provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. The company is also involved in the sale of organic food and beverages; provision of technology development, transfer, and consulting services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei, Taiwan.